Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Science · 04.08.2023 · 381 (6657)
DOI: 10.1126/science.add5787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 04.08.2023. Verfasst von Kai Wang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Female Fertility Promotion, Center for Reprod…. Hauptthemen laut MEDLINE: Bacteroides, Diabetes Mellitus, Type 2, Dipeptidyl Peptidase 4, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 86 Literaturangaben.
Abstract (Originalsprache)
A mechanistic understanding of how microbial proteins affect the host could yield deeper insights into gut microbiota–host cross-talk. We developed an enzyme activity–screening platform to investigate how gut microbiota–derived enzymes might influence host physiology. We discovered that dipeptidyl peptidase 4 (DPP4) is expressed by specific bacterial taxa of the microbiota. Microbial DPP4 was able to decrease the active glucagon like peptide-1 (GLP-1) and disrupt glucose metabolism in mice with a leaky gut. Furthermore, the current drugs targeting human DPP4, including sitagliptin, had little effect on microbial DPP4. Using high-throughput screening, we identified daurisoline-d4 (Dau-d4) as a selective microbial DPP4 inhibitor that improves glucose tolerance in diabetic mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Peking University, Beijing, China.
- Center for Obesity and Metabolic Disease Research, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
- Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
- National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital), Beijing, China.
- Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Department of Chemical Biology, College of Chemistry and Molecular Engineeri…
ORCID-Profile: Kai Wang, Zhiwei Zhang, Jing Hang, Jia Liu, Fusheng Guo, Yong Ding, Meng Li, Qixing Nie, Yi Zhang, Jue Wang, Rui Bao, Yanli Pang, Guang Wang, Frank J Gonzalez, Xiaoguang Lei, Jie Qiao, Changtao Jiang
Zitieren
APA
Wang, K., Zhang, Z., Hang, J., Liu, J., Guo, F., Ding, Y., Li, M., Nie, Q., Lin, J., Zhuo, Y., Sun, L., Luo, X., Zhong, Q., Ye, C., Yun, C., Zhang, Y., Wang, J., Bao, R., Pang, Y., …, & Jiang, C. (2023). Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Science, 381(6657). https://doi.org/10.1126/science.add5787
Vancouver
Wang K, Zhang Z, Hang J, Liu J, Guo F, Ding Y, et al. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Science. 2023;381(6657). doi:10.1126/science.add5787
BibTeX
@article{Wang2023,
author = {Wang, Kai and Zhang, Zhiwei and Hang, Jing and Liu, Jia and Guo, Fusheng and Ding, Yong and Li, Meng and Nie, Qixing and Lin, Jun and Zhuo, Yingying and Sun, Lulu and Luo, Xi and Zhong, Qihang and Ye, Chuan and Yun, Chuyu and Zhang, Yi and Wang, Jue and Bao, Rui and Pang, Yanli and Wang, Guang and Gonzalez, Frank J and Lei, Xiaoguang and Qiao, Jie and Jiang, Changtao},
title = {Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target},
journal = {Science},
year = {2023},
volume = {381},
number = {6657},
doi = {10.1126/science.add5787}
}
EUVIMED